These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 994932)

  • 1. Treatment of calcinosis circumscripta and Raynaud's phenomenon.
    Meyers D
    Med J Aust; 1976 Sep; 2(12):457. PubMed ID: 994932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-arterial reserpine for Raynaud's syndrome. Systemic reactions without therapeutic benefit.
    Surwit RS; Gilgor RS; Duvic M; Allen LM; Neal JA
    Arch Dermatol; 1983 Sep; 119(9):733-5. PubMed ID: 6614959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Intra-arterial reserpine in Raynaud's disease and syndrome].
    Arcas Meca R; Ono Okabe S; Barroso-Moguel R; Quijano Pitman F
    Arch Inst Cardiol Mex; 1972; 42(2):260-8. PubMed ID: 5028993
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of intra-arterial reserpine in patients suffering from Raynaud's phenomenon.
    Acevedo A; Reginato AJ; Schnell AM
    J Cardiovasc Surg (Torino); 1978; 19(1):77-84. PubMed ID: 627597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of raynaud's disease and phenomenon with intraarterial reserpine (author's transl)].
    González Folch M; Saffie F
    Rev Med Chil; 1976 Jan; 104(1):21-4. PubMed ID: 788084
    [No Abstract]   [Full Text] [Related]  

  • 6. CRST syndrome with persistent gastrointestinal bleeding. (Calcinosis, raynaud's phenomenon, sclerodactyly and telangiectasia).
    Kolodny M; Baker WG
    Gastrointest Endosc; 1968 Aug; 15(1):16-7. PubMed ID: 5302707
    [No Abstract]   [Full Text] [Related]  

  • 7. [Subcutaneous calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia (CRST syndrome): an association of interest in hepatology (author's transl)].
    Dubois A; Jourdan J; Blotman F; Balmes JL; Janbon F; Bertrand A; Michel H
    Gastroenterol Clin Biol; 1978 Oct; 2(10):805-9. PubMed ID: 729977
    [No Abstract]   [Full Text] [Related]  

  • 8. Intra-arterial administration of reserpine. Its use in patients with Raynaud's disease or Raynaud's phenomenon.
    Romeo SG; Whalen RE; Tindall JP
    Arch Intern Med; 1970 May; 125(5):825-9. PubMed ID: 5444311
    [No Abstract]   [Full Text] [Related]  

  • 9. Reserpine in Raynaud's phenomenon.
    Dimitriu CG; Florian G
    Lancet; 1970 Dec; 2(7684):1199. PubMed ID: 4098477
    [No Abstract]   [Full Text] [Related]  

  • 10. Raynaud's disease and phenomenon, a medical approach.
    Willerson JT; Decker JL
    Am Heart J; 1971 Oct; 82(4):572-3. PubMed ID: 5111239
    [No Abstract]   [Full Text] [Related]  

  • 11. Cutaneous microcirculation in systemic sclerosis and response to intra-arterial reserpine.
    Nilsen KH; Jayson MI
    Br Med J; 1980 Jun; 280(6229):1408-11. PubMed ID: 7427134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reserpine and Raynaud's phenomenon.
    Uman SJ
    Ann Intern Med; 1972 Dec; 77(6):1005. PubMed ID: 4644162
    [No Abstract]   [Full Text] [Related]  

  • 13. Raynaud's phenomenon preceding acute lymphocytic leukemia.
    Powell KR
    J Pediatr; 1973 Mar; 82(3):539-40. PubMed ID: 4512401
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of reserpine in Raynaud's phenomenon.
    Kontos HA; Wasserman AJ
    Circulation; 1969 Feb; 39(2):259-66. PubMed ID: 5763842
    [No Abstract]   [Full Text] [Related]  

  • 15. [Primary biliary cirrhosis associated with CRST syndrome (calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia). Effect of cytostatic therapy in a case of our observation].
    Amoroso A; Di Rosa R; Afeltra A; Bolognesi A; Ferri GM; Bonomo L
    Recenti Prog Med; 1988 Apr; 79(4):169-72. PubMed ID: 3393727
    [No Abstract]   [Full Text] [Related]  

  • 16. Reserpine treatment of Raynaud's disease.
    Nobin BA; Nielsen SL; Eklov B; Lassen NA
    Ann Surg; 1978 Jan; 187(1):12-6. PubMed ID: 619795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sympatholytic effect of intra-arterial reserpine in sclerodermia and Raynaud's disease].
    Acevedo A; Palacios JM; López R; Palma F
    Rev Med Chil; 1984 Jun; 112(6):553-8. PubMed ID: 6515168
    [No Abstract]   [Full Text] [Related]  

  • 18. Calcinosis cutis of the fingertip associated with Raynaud's phenomenon.
    Yang JH; Kim JW; Park HS; Jang SJ; Choi JC
    J Dermatol; 2006 Dec; 33(12):884-6. PubMed ID: 17169096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid crystal thermography: a measure of therapeutic response to reserpine given intra-arterially.
    Chandler C
    South Med J; 1976 May; 69(5):614-5. PubMed ID: 1273622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CRST syndrome (calcinosis, Raynaud's phenomenon, sclerodactyly and telangiectasia).
    Brown AE
    Br J Oral Surg; 1976 Nov; 14(2):137-42. PubMed ID: 1070339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.